MedCalcHub stores your favorites, history, and saved calculations locally in your browser using localStorage. This data never leaves your device.
Optional advertising, when enabled, may use third-party cookies or similar technologies. You can accept or reject advertising below.
Estimates creatinine clearance (CrCl) for medication dosing using the Cockcroft-Gault equation.
Clinical decision-support tool for qualified healthcare professionals. Results are not a diagnosis and should not replace professional clinical judgment.
The Cockcroft-Gault equation estimates creatinine clearance (CrCl) from age, weight, sex, and serum creatinine. It was the first widely adopted method for estimating renal function before direct GFR measurement became practical, and it remains embedded in many medication dosing guidelines. The equation outputs an absolute CrCl in mL/min using actual body weight, adjusted for sex. The estimated creatinine clearance should not be equated with measured GFR or with eGFR reported by MDRD or CKD-EPI. Those equations report GFR normalized to body surface area (mL/min/1.73m2), whereas Cockcroft-Gault outputs an absolute clearance (mL/min). Different equations also require different serum creatinine units (notably mg/dL versus micromol/L); for the standard form of this equation, creatinine must be entered in mg/dL. Converting from micromol/L requires dividing by 88.4 before entry. The estimate is most reliable in adults with stable renal function and body weight near the population average. It becomes progressively less accurate at extremes of body size, in the very old or very young, with impaired muscle mass, amputation, pregnancy, ascites, severe edema, or rapidly changing renal function. Patients with significantly abnormal weight should have dosing decisions cross-referenced against the specific equation recommended in the source guideline. This estimate supports clinical decision-making in a medication dosing context and is not a diagnosis of kidney disease. Transplant recipients, patients with unusual body composition, or anyone with rapidly changing creatinine should have dosing confirmed against the guideline-appropriate equation. Specialist review may be warranted when the result is discordant with the clinical picture.
Specialty
Internal MedicineCategory
NephrologyDifficulty
Basic
Estimated Time
30 seconds
Version
1.0
Last Updated
2026-08-06
Formula
Keywords
Normal Range
90–120 mL/min
| Classification | Range |
|---|---|
Normal renal function | ≥90 |
Mild renal impairment | 60–89 |
Moderate renal impairment | 30–59 |
Severe renal impairment | 15–29 |
Kidney failure | <15 |
Estimates creatinine clearance (CrCl) to guide drug dosing adjustments, particularly for renally cleared medications.
Creatinine clearance is estimated as CrCl = ((140 - age) x weight) / (72 x serum creatinine), multiplied by 0.85 for females. Weight is in kg and creatinine in mg/dL.
Age in years, subtracted from 140 in the numerator.
Body weight in kilograms used in the numerator.
Biological sex; females receive a 0.85 correction factor.
Serum creatinine in mg/dL, used in the denominator.
CrCl >90 mL/min is normal. 60–89 is mildly decreased. 30–59 is moderately decreased. 15–29 is severely decreased. <15 indicates kidney failure. Use the result to adjust medication doses per drug-specific guidance.
The Cockcroft-Gault equation remains the most widely referenced method for drug dosing adjustments in renal impairment, as most drug labeling and pharmacokinetic studies used this equation for dose adjustments.
A 70-year-old man weighing 75 kg has a serum creatinine of 1.4 mg/dL.
Inputs:
Expected Result: CrCl ≈ (140 − 70) × 75 / (72 × 1.4) ≈ 52.1 mL/min. This indicates moderate renal impairment and may require dose adjustment for renally cleared drugs.
Use Cockcroft-Gault when adjusting medication doses, as many drug labels still reference CrCl from this equation.
Use actual body weight by default. Adjusted body weight may be used in obese patients per institutional guidelines.
Disclaimer: This calculator is intended for educational and clinical decision support purposes only. Drug dosing decisions should always consider the individual patient's clinical context and current drug labeling.
Medication dosing adjustment.
Less accurate for estimating true GFR.
Routine kidney function assessment and CKD staging.
Not preferred for medication dosing.
Historical comparison.
Largely replaced by CKD-EPI.